Cell Rising Capital

Overview

Cell Rising Capital is a Hong Kong-based venture capital firm specializing in angel to series A funding for startups across Europe and Asia. They are dedicated to forging cross-continental connections, enabling the exchange of innovative technologies between Europe and Asia. Their strategic focus encompasses diverse sectors, such as advanced manufacturing, AI, biotech, EV, fintech, medtech, and sustainability. Cell Rising Capital is a venture capital investment on cutting-edge technologies and artifical intelligence.

Year Founded

2020

Portfolio Companies

Website

cellrising.com

Investments

Cell Rising Capital investments
Company	Date	Stage	Lead
Springdel	Jun 2022	Seed	Lead
Hex Trust	Mar 2022	Series B	Co-investor
Hex Trust	Oct 2021	Series A Extension	Co-investor
Wrisk	May 2021	Crowdfunding	Co-investor
Hex Trust	Mar 2021	Series A	Co-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Unlock portfolio analytics

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Unlock portfolio analytics

FAQ

Firmographic Details

HeadquartersHong Kong

Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?